FDA Letters to the industry
(Warning Letter and Untitled Letter)
|
If a person or firm violates the Federal Food, Drug and Cosmetic Act (FD&C Act), FDA may give them an opportunity to take voluntary and prompt action to correct the violation before FDA initiates an enforcement action. FDA will issue either a Warning Letter or an Untitled Letter, depending upon the nature of the violation.
FDA uses Warning Letters for violations that may lead to enforcement action if they are not promptly and adequately corrected. FDA uses Untitled Letters for violations that are not as significant as those that trigger warning letters. Unlike a Warning Letter, an Untitled Letter does not include a statement warning that failure to promptly correct a violation may result in an enforcement action.
An Untitled Letter cites violations that do not meet the threshold of regulatory significance for a Warning Letter. An Untitled Letter differs from FDA warning letter in following aspects.
Warning Letter VS Untitled Letter
|
Key Words
FDA Violence, FDA letters to Industry, Issuance of Warning letter, Issuance of Untitled letter, Regulatory significance of warning letter.
|
0 Comments